MedTrace Logo

Exercise Programs in Women With PCOS

NCT07509762 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2026-04-03

No results posted yet for this study

Summary

This study aims to investigate the effectiveness of a digital rehabilitation-supported combined exercise program in women with Polycystic Ovary Syndrome (PCOS). Participants aged 18-40 years will be randomly assigned to one of three groups: a digital rehabilitation group, a face-to-face exercise group, and a physical activity counseling group. The intervention will last 8 weeks, with exercise performed three times per week. Outcomes will include DNA methylation, hormonal and metabolic parameters, anthropometric measurements, body composition, muscle strength, basal metabolic rate, physical activity level, quality of life, menstrual cycle regularity, exercise adherence and satisfaction.

Conditions

  • Polycystic Ovarian Syndrome (PCOS)
  • Digital Rehabilitation
  • DNA Methylation
  • Exercise

Interventions

BEHAVIORAL

Face-to-face exercise

Participants will perform the same combined exercise program (aerobic and resistance exercises) delivered in person by the study team. Sessions are supervised directly in a clinical setting.

BEHAVIORAL

Digital rehabilitation

Participants will perform a combined exercise program (aerobic and resistance exercises) through a digital rehabilitation platform.

Sponsors & Collaborators

  • Biruni University

    lead OTHER

Principal Investigators

  • Buket Akıncı, Prof. Dr. · Biruni University, Faculty of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-01-15
Completion
2027-03-25

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07509762 on ClinicalTrials.gov